Tag Archives: WSJ

WSJ: Emulex Sellers’ Price Is Around $12

February 2, 2010 – 11:58 pm

Two top officials at Emulex Corp. sold a combined $574,972 in company stock last week, the first sales in more than two years from any Emulex insider. Chairman Paul Folino and Chief Executive James McCluney sold at prices of about $12 a share using trading plans established in advance of the sales, regulatory filings show. […]

By form4oracle | Posted in Insider Trading Activity | Also tagged , , | Comments Off on WSJ: Emulex Sellers’ Price Is Around $12

WSJ: Married Executives Scoop Up Optimer Stock

January 12, 2010 – 11:31 pm

A married couple in the top management of Optimer Pharmaceuticals has gone bullish on the stock in recent weeks. Through option exercises and open-market purchases, Chief Executive Michael Chang and Chief Operating Officer Tessie Che have raised their holdings by more than 16% as the drug developer awaits results from an important clinical trial. The […]

By form4oracle | Posted in Insider Trading Activity | Also tagged , | Comments Off on WSJ: Married Executives Scoop Up Optimer Stock

WSJ: Dril-Quip Sale Mightn’t Mean Much

December 15, 2009 – 10:14 pm

A co-chairman of Dril-Quip sold $22.8 million in company stock this month, but observers said his sales shouldn’t spook investors. Through a trust, Larry Reimert sold 428,484 shares of the provider of offshore-drilling equipment, according to Form4Oracle.com, a Web site that tracks and interprets insider-trading signals. The sales were Mr. Reimert’s first since 2007. Mr. […]

By form4oracle | Posted in Insider Trading Activity | Also tagged , | Comments Off on WSJ: Dril-Quip Sale Mightn’t Mean Much